Moreover, recurrent glioma cells can delete or amplify the IDH1 mutant or wild-type allele, which is followed by clonal expansion and recurrence of tumors that resembled the G-CIMP-low primary subtype. The gene discussed is IDH1; the disease is central nervous system cancer.